Quantcast

Latest research Stories

2014-07-26 00:20:52

REDWOOD CITY, Calif., July 25, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Company's new drug application (NDA) for Zalviso(TM) (sufentanil sublingual tablet system). The Company is currently...

2014-07-25 12:25:15

COSTA MESA, Calif., July 25, 2014 /PRNewswire-iReach/ -- Full Service CRO WCCT Global welcomes Peter Nieto as the new Vice President of Business Development. Peter has been in the pharmaceutical industry for over 30 years in a number of different business development positions with some of the largest CROs in the industry. These positions were primarily related to business development/sales management and marketing. The experience he has obtained over the past 30 years makes him a...

2014-07-24 23:13:47

DZS Clinical Services announced today that SBI Pharmaceuticals, the leading expert in research, development, and manufacturing of 5-ALA, has entered into a preferred provider agreement with DZS to manage several clinical programs related to the development of 5-ALA. Bound Brook, NJ (PRWEB) July 24, 2014 As part of the long-term strategic approach, DZS expects to manage numerous projects in the MENA region during 2014 with potential global expansion. "We are delighted to have a...

2014-07-24 16:27:50

SOUTH PLAINFIELD, N.J., July 24, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its second quarter 2014 financial results and provide an update on the company's business and outlook on Thursday, August 7, 2014 at 8:30 a.m. (ET) before the opening of the market. http://photos.prnewswire.com/prnvar/20010919/PTCLOGO The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152...

2014-07-24 12:27:52

MENLO PARK, Calif., July 24, 2014 /PRNewswire/ -- SRI International has been awarded a new $49 million, seven-year contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to conduct preclinical development of potential therapies for HIV infection and AIDS. The contract supports the development of drugs to treat HIV and AIDS and the complications and opportunistic infections associated with the disease, as well as...

2014-07-24 08:33:44

Based on encouraging progression-free survival data, Lpath extends the study to a second cohort and considers additional proof-of-concept studies SAN DIEGO, July 24, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, reported interim results in a Phase 2a single-arm, open-label trial where ASONEP(TM) is being investigated as a treatment for metastatic renal cell carcinoma (RCC) in patients that have failed at least one...

2014-07-23 23:30:15

Next Session of Clinovo’s Hands-On SAS & CDISC TechTrainings to Commence on 9th September, 2014 Held in Sunnyvale (CA) and Streamed Online Sunnyvale, CA (PRWEB) July 22, 2014 The next session of Clinovo’s TechTrainings will begin on September 9th, 2014 and will comprise of the increasingly popular ‘Base SAS’ and ‘CDISC Standards: Theory and Application’ classes. The TechTrainings is a series of technical hands-on classes for entry-level to experienced clinical trial...

2014-07-23 16:26:42

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Partial Seizure Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243634/Partial-Seizure-Global-Clinical-Trials-Review-H2-2014.htmlPartial Seizure Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Partial Seizure Global Clinical Trials Review, H2, 2014" provides data on the Partial Seizure clinical trial scenario. This report provides...

2014-07-23 16:26:38

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Neonatal Seizures Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243633/Neonatal-Seizures-Global-Clinical-Trials-Review-H2-2014.htmlNeonatal Seizures Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Neonatal Seizures Global Clinical Trials Review, H2, 2014" provides data on the Neonatal Seizures clinical trial scenario. This report...

2014-07-23 16:26:32

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243630/Intracerebral-Hemorrhage-Global-Clinical-Trials-Review-H2-2014.htmlIntracerebral Hemorrhage Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014" provides data on the Intracerebral Hemorrhage...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.